{
    "nctId": "NCT04517318",
    "briefTitle": "Treatment After Palbociclib-containing Regimens",
    "officialTitle": "A Multi-center Study of the Treatment Patterns and Clinical Outcomes of Subsequent Therapies After Progression on Palbociclib in HR+/HER2- Metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "PFS",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. woman, age \\> 18 years old\n2. Diagnosed with HR+/HER2- Metastatic Breast Cancer\n3. Patients received at least one-cycle next-line treatment after progression on combined palbociclib and endocrine therapy\n4. Complete medical history was available\n\nExclusion Criteria:\n\n1. Medical history was incomplete",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}